News > Coronavirus vaccine: DCGI to decide on Serum Institute's clinical trials today
Coronavirus vaccine: DCGI to decide on Serum Institute's clinical trials today
Business Today | 14/09/2020 01:00 PM | Click to read full article
On Saturday, the Pune-based drug manufacturer said that it will resume clinical trials of AstraZeneca's COVID-19 candidate after getting permission from the DCGI.
Meanwhile, pharma giant AstraZeneca has resumed the clinical trial of its COVID-19 vaccine in the UK, following confirmation by the Medicines Health Regulatory Authority (MHRA) that the trials are safe. The human trials in the UK resumed days after getting paused due to a reported side effect in a patient.
